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Abstract: Gut microbiota are critical to many aspects of human health including immune 
and metabolic health. Long-term diet influences the community structure and activity of 
the trillions of microorganisms residing in the human gut, but it remains unclear how the 
human gut microbiome responds to short-term intervention with dietary fiber. This study 
explored the effects of mixed dietary fibers on gut microbiota in young, healthy people. 
Twelve healthy, young adults participated in a randomized, crossover trial comparing the 
effects of polyglucan, inulin and resistant malt dextrin on gut microbiota composition and 
bacterial abundances. During the study, the subjects followed their normal diets without any 
constraints. Microbial community profiles were determined by absolute quantification 16S 
rRNA gene amplicon sequencing. Mixed model analysis did not reveal an effect of dietary 
intervention on microbial community structure. At the genus level, dietary fiber intervention 
for 4 days significantly promoted the growth of Alloprevotella, Parabacteroides and 
Parasutterella and inhibited the growth of Adlercreutzia, Anaerovorax, Enterococcus, 
Intestinibacter and Ruminococcus2 compared with the baseline. Addition of whey albumen 
powder for 4 days promoted the growth of Corynebacterium, Collinsella, Olsenella and 
Lactococcus but interfered with the growth of Megasphaera. Our results should be corro-
borated by randomized clinical trials with large sample size. 
Keywords: dietary fiber, gut microbiota, short-term intervention
Introduction
Gut microbiota refers to the microorganisms harbored by the digestive tract of the 
human body and is regarded as one of the key organs of the human body.1 Our 
understanding of the biological roles of the gut microbiome, which include mod-
ulation of glucose and lipid metabolism,2 has increased dramatically over the past 
decade. Studies have shown that environmental factors such as diet and drugs have 
a greater impact on gut microbiota than genetic factors. The diversity of gut 
microbiota and the proportion of organisms belonging to certain genera are differ 
significantly according to the various dietary patterns of the host.3,4 Addition of 
prebiotics to the host diet can increase the abundance of microorganisms in certain 
families by more than 30%,5 and changes in gut microbiota can directly affect the 
metabolism of glucose and lipid;6 therefore, controlling the balance of the gut 
microbiota through dietary intervention may improve host metabolism and thereby 
reduce the onset of metabolic diseases. Adding dietary fiber to the diet is one of the 
most common dietary interventions for obese and diabetic patients.
Dietary fiber is defined as edible carbohydrate polymers with three or more 
monomeric units that are resistant to endogenous digestive enzymes. It is neither 
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hydrolyzed nor absorbed in the small intestine.7 Dietary 
fiber, the seventh most important dietary nutrient, is asso-
ciated with various diseases of human body, especially 
metabolic diseases.8 Multiple cohort studies have indicated 
that dietary fiber supplementation can improve the meta-
bolism of subjects and reduce the risk of developing meta-
bolic diseases such as obesity and type 2 diabetes.9–12
Current evidence regarding the effect of dietary fiber 
on the gut microbiota has been informed by specific pre-
biotic fiber interventions13, whole diet interventions14 and 
cross-sectional associations,15 yet there is no consistent 
conclusion on how dietary fiber alters the composition 
and diversity of gut microbiota since the microbial 
response to dietary fiber is highly individualized.16–19 
More importantly, studies looking at the effects of dietary 
fiber on gut microbiota in healthy individuals, excluding 
infection or disease state, are limited. The influence of 
dietary fiber on the gut microbiota of healthy people may 
be even more important than that in unhealthy people, 
because intervention in healthy people before the occur-
rence of disease is the basis for preventing disease. Long- 
term dietary fiber intervention influences the structure and 
activity of the trillions of microorganisms residing in the 
human gut, but how rapidly the human gut microbiome 
responds to short-term dietary fiber intervention remains 
unclear. In this study, we conducted a randomized, con-
trolled, cross-over trial involving a daily dietary fiber 
intervention in healthy volunteers. We evaluated the effect 
of mixed dietary fibers comprising polyglucan, inulin and 
resistant malt dextrin on gut microbiota composition and 
bacterial abundances among healthy volunteers.
Methods
Study Design and Participants
The study was registered as a clinical trial (http://www.chictr. 
org.cn/, China Clinical Trial Registration, 
ChiCTR1900027845) and carried out at Xinjiang Medical 
University (Urumqi, China). The study was conducted 
according to the Declaration of Helsinki. The Medical 
Ethics Committee of the First Affiliated Hospital of 
Xinjiang Medical University approved the study protocol 
(20191113-05). Participants were recruited through public 
advertisements. The protocol was explained to the volun-
teers, and their written informed consent was obtained. 
Inclusion criteria were as follows: age from 18 to 35; BMI 
[body weight (kg)/height (m2)] between 18 and 28; no intake 
of antibiotics, laxatives or other gastrointestinal medications 
for 3 months prior to the beginning of the study. A 4 mL 
venous blood sample was collected after at least 8 hours of 
fasting for blood glucose determination and blood and 
laboratory testing. The First Affiliated Hospital of Xinjiang 
Medical University performed blood glucose and blood lipid 
assays using auto-analyzers. The test methods and require-
ments complied with national clinical test operating proce-
dures in China.
Twelve healthy, young, adults (six females and six males, 
aged from 22 to 32 years) with no history of gastrointestinal 
problems participated in the study. Subjects were randomly 
assigned to receive each dietary intervention during the 4-day 
treatment period with a 4-day washout period. Six subjects 
followed a first round of 20 g mixed dietary fibers per day for 
4 days, followed by a 4-day washout, then a second round of 
40 g whey albumen powder per day for 4 days. The other six 
participants followed the exact same sequence but with 40 
g whey albumen powder per day in the first round and 20 
g mixed dietary fibers per day in the second round. The 
mixed dietary fibers consisted of polyglucan, inulin and 
resistant malt dextrin (Revilife, China). Whey albumen pow-
der was composed of hydrolyzed whey protein peptide 
(Revilife, China). Data from all subjects were separated 
into three groups: Group A represented data collected after 
every dietary fiber intervention. Group B represented data 
collected after every protein powder intervention. Group 
P represented summarized data from the washout period 
and baseline data.
During the study, the subjects followed their normal diet 
without any constraints. All diets were consumed ad libitum 
without caloric restrictions. Notepads were used to log diet 
and bowel movements during the experiment. The partici-
pants’ normal bowel frequencies ranged from three times 
a day to once every other day. All participants logged their 
diet for 3 days before the study began using the 24-hour diet 
review method. The Feihua nutrition calculator V2.7.5.4 
(Feihua, China) was used to calculate the percentage of 
heat energy from carbohydrate, protein and fat. The subjects 
visited the Xinjiang Medical University five times to pro-
vide stool samples and were monitored by a clinical dieti-
tian throughout the study. Metabolic measurements were 
made after overnight fasting.
Fecal Sample Collection and Storage
For each participant, five stool samples were taken during 
the study. The first sample was taken 4 days before the 
intervention start, the second sample was taken after the 
first-round intervention, the third sample was taken after 
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the 4-day washout period, the fourth sample was taken 
after the second-round intervention, and the fifth sample 
was taken 4 days after the fourth sample. The stool sample 
collected for each period was from the first bowel move-
ment during the stipulated time. The study design is shown 
in Figure 1. Some subjects were unable to defecate on the 
days of their visit, and a total of 52 stool samples were 
collected in this study. Stool samples for gut microbiota 
composition were collected in sterile tubes and placed into 
specimen containers; these were further surrounded by 
frozen gel packs cooled to −20°C, delivered to the labora-
tory in coolers within 2 h and then stored at −80°C.
Microbial Community Analysis by 16S 
rRNA Gene Sequencing
Total DNA was extracted from all 52 stool samples using 
a QIAamp stool DNA mini kit (Qiagen, Germany) accord-
ing to the manufacturer’s instructions. DNA was quantified 
using a NanoDrop ND-1000 spectrophotometer (Rockland 
Company, USA) and stored at −80°C for later use. The 
genomic DNA was used to construct an amplicon library 
by amplifying the V3~V4 region of the 16S rRNA gene. 
PCR was performed using the following conditions: initial 
denaturation at 95°C for 3 min; 25 cycles of 95°C for 30 s, 
55°C for 30 s, and 72°C for 30 s; and a final extension step 
at 72°C for 7 min. After the reaction, all reaction products 
were detected using 1.5% agar gel electrophoresis (ethi-
dium bromide staining) to determine the size of amplified 
fragments. A QIAquick GelExtraction Kit (QIAGEN, 
Germany) was used to recover and purify target bands. 
An Illumina Miseq high-throughput sequencing platform 
(Illumina) was used to sequence the PCR products in the 
16S RNA V3~V4 region; the sequencing type was PE250. 
Reads with low quality were filtered out from the drop-out 
data to obtain clean data. The software FLASH 
(FastLength Adjustment of Short reads V1.2.11) was 
used for sequence stitching. Reads obtained from double- 
end sequencing were spliced into Tags. Optimised Tags 
were grouped into operational taxonomic units (OTUs) at 
97% similarity, after obtaining the representative OTU 
sequence; representative OTU sequences were compared 
with known Greengene (V201305) sequences for species 
annotation through the Ribosomal Database Project 
Classifier (V2.2) software to obtain community composi-
tion information for each sample.
DNA of total bacteria in feces was extracted using 
a QIAamp® Fast DNA Stool Mini Kit. Absolute quantifi-
cation by 16S rRNA gene pyrosequencing of the DNA 
samples was carried out by Shanghai Genesky 
Biotechnologies Inc. China. For each sample, the V3~V4 
region of the bacterial 16S ribosomal RNA gene was 
chosen for amplification and sequenced on an Illumina 
MiSeq platform. Nine different spike-in sequences with 
four different concentrations (104, 105, 106, or 107 copies 
of internal standards) were added to the sample DNA 
pools. The spike-in sequences contained conserved regions 
identical to those of natural 16S rRNA genes and artificial 
variable regions different from nucleotide sequences in the 
public databases, which worked as internal standards and 
allowed absolute quantification across samples.20,21 All 
results were based on sequenced reads and operational 
taxonomic units (OTUs).
Figure 1 Intervention study design.
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Statistical analysis was carried out using SAS software 
(SAS 9.4; SAS Institute Inc. Cary, NC, USA). Results 
are presented as means ± SEMs, and log10 transformation 
was performed when necessary. Differences in absolute 
abundances of taxonomic groups were investigated at the 
levels of phylum, class, order, family, genus and species. 
The average absolute abundance of taxa in sample 1, 
sample 3 and sample 5 of the 12 participants were selected 
as baseline (group P). Comparisons were made between 
baseline and post-intervention for each diet intervention 
group and between the two diet intervention groups (group 
A and group B). Absolute abundances of taxa were ana-
lyzed using a mixed linear model with intervention group; 
the order of the interventions was used as the fixed effect, 
and subjects were used as the random effect. Differences 
in absolute taxon abundances between the two diet inter-
ventions and between the baseline and post-intervention, 
together with their 95% confidence intervals (CI), were 
derived from the mixed model. In all cases, the level of 
significance was set at 5%.
The α-diversity values for each sample were described 
with the use of the Chao1, Observed and Shannon diversity 
indices. The same method used to determine absolute taxon 
abundances was implemented for analyzing α-diversity. 
The β-diversity of intervention groups and baseline was 
also compared by performing principal co-ordinates analy-
sis (PCoA) on weighted WuniFrac (a distance metric used 
for comparing biological communities) distances.
Results
Participant Characteristics
Twelve healthy, young adults (six males and six females) 
were involved in the current study; their baseline charac-
teristics are provided in Table 1. None of them had a BMI 
beyond 28 kg/m2. The blood glucose, total cholesterol, 
triglyceride, high-density lipoprotein and low-density lipo-
protein of all subjects were in the normal range.
Food Logs and Dietary Questionnaires
Three repeated 24-hour dietary food lists were used to 
record the diet of all subjects before and after the study 
period. We analyzed the percentage of heat energy from 
carbohydrate, protein and fat among the 12 participants. 
The results are shown in Table 2.
Microbial Community Analysis
The effects of dietary fibers on the gut microbiota were 
determined by high-throughput sequencing analysis. We 
analyzed α-diversity indices [observed species and Chao 1 
index (OTU richness estimation), and Shannon index 
(OTU evenness estimation)] using a mixed linear model. 
Table 1 Baseline Characteristics of Subjects
Characteristic Group: Fibers-Protein  
(Mean±SD; n=6)




Age (year) 27 (2.0) 26 (4.0) 27(3.0)
Sex (female/male) 3/3 3/3 6/6
Ethnicity
Han 5 4 9
Non-Han 1 2 3
Height (cm) 166.3±5.6 170.3±6.3 168.3±6.1
Weight (kg) 61.4±14.1 64.1±13.3) 62.8±13.2
Waist circumference (cm) 76.0±8.1 77.8±7.8 76.9±7.6
Blood glucose (mmol/L) 4.70±0.51 4.99±0.34 4.84±0.44
Triglyceride (mmol/L) 0.94±0.52 0.93±0.45 0.93±0.46
Total cholesterol (mmol/L) 4.04±0.56 4.52±0.34) 4.27±0.68
High density lipoprotein (mmol/L) 1.38±0.36 1.46±0.34 1.42±0.34
Low density lipoprotein (mmol/L) 2.31±0.70 2.69±0.81 2.49±0.75
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The results indicated only a slight difference in Observed, 
Chao1, and Shannon indices based on absolute quantifica-
tion between the two diet interventions, and between base-
line and post-intervention data (Table 3). We also 
compared the β-diversity between the two dietary inter-
ventions, and between the baseline and post-intervention 
samples by performing PCoA on weighted WuniFrac dis-
tances. The dietary fiber intervention group and the other 
groups were distinctly separate; however, there were only 
minor differences among the diet interventions, and among 
the baseline and post-intervention samples (Figure 2). In 
conclusion, mixed model analysis revealed that dietary 
interventions had no effects on microbial community 
structure.
Bacterial composition was determined at the phylum, 
class, order, family, genus and species levels. At the genus 
level, compared with the baseline, 4 days of dietary fiber 
intervention boosted the growth of Alloprevotella, 
Parabacteroides and Parasutterella notably; the differences 
with 95% CI between dietary fiber intervention and baseline 
of log10 transformed absolute bacterial abundance were 0.70 
(0.09 to 1.32), 2.68 (1.90 to 3.47) and 0.94 (0.14 to 1.74), 
with p values of 0.026, <0.001 and 0.022, respectively. Four 
days of dietary fiber intervention also dramatically prevented 
the growth of Adlercreutzia, Anaerovorax, Enterococcus, 
Intestinibacter and Ruminococcus2; the differences with 
95% CI between dietary fiber intervention and baseline of 
log10 transformed absolute bacterial abundance were −1.14 
(−1.72 to −0.55), −0.87 (−1.56 to −0.18), −1.78 (−3.22 to 
−0.33), −2.15 (−3.43 to −0.88) and −1.03 (−1.66 to −0.39), 
with p values of <0.001, 0.015, 0.018, 0.002 and 0.002, 
respectively. At the genus level, the change in log10 trans-
formed absolute bacterial abundance between the 4 days of 
dietary fiber group and the 4 days of whey albumen powder 
group exhibited the same trend as the change in log10 trans-
formed absolute bacterial abundance between the 4 days of 
dietary fiber group and the baseline. At the genus level, 
compared with the baseline, 4 days of whey albumen powder 
intervention fostered considerable growth of 
Corynebacterium, Collinsella, Olsenella and Lactococcus; 
the differences with 95% CI between 4 days of whey 
albumen powder intervention and baseline of log10 trans-
formed absolute bacterial abundance were 1.36 (0.50 to 
2.21),0.89 (0.33 to 1.44), 1.19 (0.25 to 2.12) and 2.67 (0.81 
to 4.53), with p values of 0.003, 0.003, 0.014 and 0.006, 
respectively. At the genus level, compared with the baseline, 
4 days of whey albumen powder intervention evidently 
impeded the growth of Megasphaera; the difference and 
95% CI between 4 days of whey albumen intervention and 
baseline of log10 transformed absolute bacterial abundance 
was −1.07 (−2.03 to −0.11), p = 0.030 (Table 4).
Discussion
We observed the effect of dietary fiber on intestinal flora by 
adding dietary fiber to the diets of healthy individuals for 4 
days, identified the bacterial species that showed notable 
changes in order to adapt to the intervention, and speculated 
on the cause of these changes.
At the taxonomic level, we found that after intervention, 
relative abundance of Parasutterella, Parabacteroides and 
Alloprevotella changed indicatively, with all bacteria showing 
an upward trend. In addition, the relative abundance of 
Enterococcus, Leuconostoc, Anaerovorax, Parvimonas 
Lachnospiraceae, Ruminococcus, Intestinibacter 
Adlercreutzia, Saccharibacteria and Raoultella were also 
affected by the intervention, showing a remarkable decline.
Numerous studies have shown that antibiotic use and 
dietary intervention (such as supplementation with probio-
tics and resistant starch) can cause changes in the structure 
of intestinal flora. Gut microbiota affects host health by 
producing short-chain fatty acids (SCFAs), altering amino 
acid metabolites and affecting bile acid metabolites.22,23
The genus of Parasutterella has been defined as a core 
component of human and mouse intestinal flora. It is one 
of the most frequently reported taxonomic units of intest-
inal betaproteobacteria, and in-depth studies over recent 
years have indicated that Parasutterella are associated 
with a variety of health outcomes.24–26 Ju27 used 
a colonization experiment of strain Parasutterella mc1 to 
prove that Parasutterella can affect the host physiology by 
altering metabolites. Succinate, one of the SCFAs pro-
duced by Parasutterella, can promote colonization of 
Table 2 Percentage of Heat Energy from Three Nutrients Among 12 Participants
Characteristic Group:Fibers-Protein Group:Protein-Fibers Total
Carbohydrate (percentage of energy) 219.1(58.7%) 197.1(59.2%) 208.1(59.0%)
Protein (percentage of energy) 64.0(18.2%) 56.8(18.3%) 60.4(18.2%)
Fat (percentage of energy) 32.0(23.1%) 41.4(22.5%) 36.7(22.8%)
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anaerobic bacteria, maintain homeostasis of gut microbiota 
and protect the host from infection.28 Succinate is also 
considered an agonist of FBPase,29 can promote gluconeo-
genesis and can improve glucose homeostasis and weight 
gain.30,31 Parasutterella also produces purine derivatives 
such as inosine, hypoxanthine and xanthine. These sub-
stances play a role in regulating host immunity and main-
taining intestinal mucosal stability.32,33
Parabacteroides is recognized as part of the core 
intestinal flora34 and has important physiological functions 
in the host. Parabacteroides distasonis is the most studied 
strain of Parabacteroides in the human gut, with most 
studies showing that P. distasonis is relatively low in 
obese, non-alcoholic fatty liver and multiple sclerosis 
patients.35–37 Wang29 confirmed that P. distasonis has the 
ability to transform bile acid, produce succinic acid and 
promote the increase of bile acid in mice, regulating host 
metabolism. Other Parabacteroides isolated from the gut, 
such as Parabacteroides goldsteinii, have similar effects.
Alloprevotella is one of the normal gut microbes of the 
human body and is widely found in the oral cavity and 
digestive tract,38 maintaining stability. The relative abun-
dance of Alloprevotella decreases obviously under condi-
tions of disease. Appropriate administration, or prebiotic 
or probiotic supplementation, increases the abundance of 
Alloprevotella.39 In our study, the addition of dietary fiber 
significantly increased the abundance of Alloprevotella, 
which was consistent with existing research results. 
However, the specific process and mechanism of 
Alloprevotella function in the improvement of body health 
are still unknown.
Our intervention of dietary fiber not only increased the 
relative abundance of some bacteria, but also reduced the 
abundance of some bacteria, mainly those of phylum 
Firmicutes such as Enterococcus, Anaerovorax, 
Ruminococcus2 and Intestinibacter, and Adlercreutzia, 
which belongs to the phylum Actinobacteria. Firmicutes 
are the dominant flora in normal human intestine, account-
ing for about 50–75%, with Bacteroides representing 10– 
50% and Proteobacteria often less than 1%.40 Some 
changes in bacterial abundance are closely related to the 
health status of the host, for example, in obese hosts, the 
relative abundance of Firmicutes is higher than that in 
normal hosts, while the intestinal flora of healthy hosts 
shows higher numbers of Bacteroides.41,42 Increases in 
proportions of bacteria will change the stability of intest-
inal flora and lead to nutritional metabolism disorders, 


































































































































































































































































































































































































































































































https://doi.org/10.2147/DMSO.S313385                                                                                                                                                                                                                               
DovePress                                                                                             
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021:14 3512
Tian et al                                                                                                                                                              Dovepress

















































































the bacteria that were reduced in our intervention were 
also susceptible in other studies; some of them are known 
to be harmful, but the influence of most bacteria with 
reduced abundance on host health status is still unclear.
It is well-acknowledged that the intestinal flora is an 
extremely complex ecosystem. Dietary fiber intervention 
alters the intestinal microbiota instead of only a single 
bacterial taxon. In our study, we found that dietary fiber 
intervention increased the relative abundance of beneficial 
bacteria significantly, including Parabacteroides, 
Parasutterella, which are related to glucose metabolism 
and lipid metabolism; meanwhile, the abundance of some 
harmful bacteria was reduced. Dietary fiber intervention 
regulated the structure of the gut microbiota. In the obser-
vation of group B, protein powder intervention practically 
counteracted the effects of dietary fiber intervention, but 
we are not clear what origin of these changes was and 
which groups of bacteria were changed by the direct action 
of intervention. Human intestinal flora exists with mutual 
restriction and interdependence according to community 
structure and proportion with the host. In further work, we 
will explore changes in the metabolic functions of the 
intestinal flora during intervention to enhance our under-
standing of the impact of dietary intervention on gut 
microbiota and host health.
Strengths and Limitations
The current evidence regarding the effect of dietary fiber 
on the gut microbiota is informed from specific prebiotic 
fiber interventions, whole diet interventions and cross- 
sectional associations, but there still was not a consistent 
conclusion on how dietary fiber alters the composition and 
Figure 2 β-Diversity comparisons of gut microbiota in stool samples that were collected at baseline (group P) and after two dietary intervention groups (A: Dietary fibers 
group, B: Whey albumen powder group).
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Table 4 Summary Statistics and Results from Mixed Model Analysis of Absolute Abundances of Genera
Genus Mean (SD) Mixed Model Analysis
A (n=11)a B (n=12)b P (n=29)c Label Difference (95% CI) p value
Adlercreutzia 5.19(1.59) 7.12(2.19) 6.38(1.94) A vs P −1.14(−1.72to-0.55) 0.000
B vs P 0.56(−0.01to1.12) 0.053
A vs B −1.70(−2.38to-1.01) <0.001
Alloprevotella 0.86(1.47) 0.78(2.72) 0.75(2.26) A vs P 0.70(0.09to1.32) 0.026
A vs B 0.78(0.06to1.50) 0.034
B vs P −0.08(−0.67to0.51) 0.792
Anaerovorax 6.69(1.31) 7.93(1.41) 7.67(1.29) A vs P −0.87(−1.56to-0.18) 0.015
B vs P 0.32(−0.34to0.99) 0.336
A vs B −1.19(−1.99to-0.38) 0.005
Enterococcus 2.75(2.47) 4.63(2.45) 4.39(2.35) A vs P −1.78(−3.22to-0.33) 0.018
B vs P 0.11(−1.29to1.51) 0.873
A vs B −1.89(−3.59to-0.19) 0.031
Intestinibacter 4.67(1.39) 7.50(1.85) 6.81(1.98) A vs P −2.15(−3.43to-0.88) 0.002
B vs P 0.72(−0.52to1.95) 0.247
A vs B −2.87(−4.37to-1.37) 0.000
Parabacteroides 12.68(1.53) 9.83(1.37) 10.10(1.18) A vs P 2.68(1.90to3.47) <0.001
A vs B 2.92(2.00to3.85) <0.001
B vs P −0.24(−1.00to0.52) 0.531
Parasutterella 8.45(2.44) 6.50(2.46) 7.33(1.62) A vs P 0.94(0.14to1.74) 0.022
A vs B 1.67(0.74to2.61) 0.001
B vs P −0.73(−1.50to0.04) 0.061
Ruminococcus2 9.76(1.51) 10.80(1.44) 10.78(1.43) A vs P −1.03(−1.66to-0.39) 0.002
B vs P 0.02(−0.59to0.63) 0.956
A vs B −1.04(−1.78to-0.30) 0.007
Corynebacterium 0.62(1.45) 1.87(1.71) 0.48(1.12) A vs P 0.11(−0.78to0.99) 0.809
B vs P 1.36(0.50to2.21) 0.003
A vs B −1.25(−2.29to-0.21) 0.020
Collinsella 9.65(1.32) 10.85(1.79) 9.85(1.70) A vs P −0.23(−0.80to0.35) 0.430
B vs P 0.89(0.33to1.44) 0.003
A vs B −1.11(−1.79to-0.44) 0.002
Olsenella 1.96(2.63) 3.56(2.94) 2.43(2.48) A vs P −0.56(−1.53to0.41) 0.251
B vs P 1.19(0.25to2.12) 0.014
A vs B −1.74(−2.88to-0.61) 0.004
Lactococcus 2.40(2.25) 5.91(2.37) 3.22(2.94) A vs P −0.79(−2.71to1.12) 0.407
B vs P 2.67(0.81to4.53) 0.006
A vs B −3.47(−5.73to-1.21) 0.004
Megasphaera 8.29(2.44) 6.33(2.44) 7.59(2.38) A vs P 0.64(−0.35to1.64) 0.199
B vs P −1.07(−2.03to-0.11) 0.030
A vs B 1.72(0.55to2.89) 0.005
Notes: aGroup A represents data from all post-dietary fiber intervention treatments. bGroup B represents data from all post-protein powder intervention treatments. 
cGroup P represents summarized data for the washout periods and baselines.
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diversity of gut microbiota. In this study, we conducted 
a randomized, controlled, cross-over trial with a daily diet-
ary fiber intervention in healthy volunteers. The aim of the 
study was to evaluate the effect of mixed dietary fibers 
consisting of polyglucan, inulin and resistant malt dextrin 
on gut microbiota composition and bacterial abundances 
among healthy volunteers. We assessed the effect of diet-
ary fiber on intestinal flora by adding dietary fiber to the 
diets of healthy individuals for 4 days and identified the 
bacterial species showing significant changes in order to 
adapt to the intervention.
We acknowledge that our study had some limitations. 
First, the sample size of our study was only 12 healthy 
adults, which was relatively small. In the future, sample 
size should be further expanded to obtain more stable 
results. Second, significant changes were observed after 
the short-term intervention. Intestinal flora changed after 
the intervention, but no further follow-up was conducted 
to observe the duration of the influence of dietary fiber and 
protein powder on intestinal flora. Third, we did not justify 
if a 4 days washout period is enough within this study 
design. Furthermore, baseline fiber intake is not reported 
from the individuals. Beneficial effects of dietary fiber on 
intestinal flora were observed in this study, but we did not 
explore the potential benefit of this change in the intestinal 
flora; future studies should further explore the mechanism 
of how dietary fiber affects intestinal flora. Due to these 
limitations, the findings should be interpreted with caution.
Conclusion
Dietary fiber intervention significantly promoted the 
growth of Alloprevotella, Parabacteroides and 
Parasutterella, and inhibited the growth of Adlercreutzia, 
Anaerovorax, Enterococcus, Intestinibacter and 
Ruminococcus2 at the genus level. The findings should 
be interpreted with caution due to the limited sample 
size, our results should be corroborated by randomized 
clinical trials with large sample size.
Data Sharing Statement
The study data are not freely available, but specific propo-
sals for future collaboration are welcome, addressed to cor-
responding author (Dai Jianghong, Email: epdjh@163.com).
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